Vaccination of weaner pigs against classical swine fever with the subunit vaccine "Porcilis® Pesti":: influence of different immunisation pattern on excretion and transmission of challenge virus

被引:0
作者
Ziegler, U [1 ]
Kaden, V [1 ]
机构
[1] Friedrich Loeffler Inst Insel Riems, Inst Infekt Med, Bundesforschungsanstalt Viruskrankheiten Tiere, D-17498 Insel Riems, Germany
来源
BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT | 2002年 / 115卷 / 7-8期
关键词
classical swine fever; domestic pigs; marker vaccine; CSFV transmission;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Excretion and transmission of CSFV after vaccination with the CSF subunit marker vaccine "Porcilis(R) Pesti" have been studied using the following different vaccination schedules: Group A - two vaccinations with an interval of 28 d, challenge 14 d after second vaccination (p.v(2).); group B - two vaccinations with an interval of 14 d, challenge 14 d later; group C - two vaccinations with an interval of 28 d, challenge at time of booster vaccination; group D - two vaccinations with an interval of 14 d, challenge 7 d p.v(2).; group E single vaccination and infection 14 d later. After infection one sentinel pig was added to the vaccinated and infected pigs of each group. A single vaccination did not induce protective immunity against a CSFV challenge. Double vaccination at a four-week interval protected piglets from clinical infection, and neither viraemia and leukopenia nor virus excretion were detected if infected 14 d p.v(2). Two vaccinations at a two-week interval followed by a challenge 7 d p.v(2). led to a short viraemia on day 5 p.i. but without excretion of CSFV. Though all other vaccination schedules induced a reduction in virus shedding and a decrease in CSFV replication, in all these cases in-contact controls became infected. The results of transmission of CSFV are discussed in relation to a potential use of subunit marker vaccines in CSF control.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 38 条
  • [1] Efficacy of the classical swine fever (CSF) marker vaccine Porcilis® Pesti in pregnant sows
    Ahrens, U
    Kaden, V
    Drexler, C
    Visser, N
    [J]. VETERINARY MICROBIOLOGY, 2000, 77 (1-2) : 83 - 97
  • [2] Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus
    Bouma, A
    De Smit, AJ
    De Jong, MCM
    De Kluijver, EP
    Moormann, RJM
    [J]. VACCINE, 2000, 18 (14) : 1374 - 1381
  • [3] Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus
    Bouma, A
    de Smit, AJ
    de Kluijver, EP
    Terpstra, C
    Moormann, RJM
    [J]. VETERINARY MICROBIOLOGY, 1999, 66 (02) : 101 - 114
  • [4] DAHLE J, 1995, BERL MUNCH TIERARZTL, V108, P20
  • [5] Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination
    de Smit, AJ
    Bouma, A
    de Kluijver, EP
    Terpstra, C
    Moormann, RJM
    [J]. VETERINARY MICROBIOLOGY, 2001, 78 (04) : 307 - 317
  • [6] Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs
    de Smit, AJ
    Bouma, A
    van Gennip, HGP
    de Kluijver, EP
    Moormann, RJM
    [J]. VACCINE, 2001, 19 (11-12) : 1467 - 1476
  • [7] Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics
    de Smit, AJ
    van Gennip, HGP
    Miedema, GKW
    van Rijn, PA
    Terpstra, C
    Moormann, RJM
    [J]. VACCINE, 2000, 18 (22) : 2351 - 2358
  • [8] Classical swine fever (CSF) marker vaccine - Trial III. Evaluation of discriminatory ELISAs
    Floegel-Niesmann, G
    [J]. VETERINARY MICROBIOLOGY, 2001, 83 (02) : 121 - 136
  • [9] Glaner M., 1984, Medicamentum, Special issue for veterinary science, P21
  • [10] Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever
    Hammond, JM
    McCoy, RJ
    Jansen, ES
    Morrissy, CJ
    Hodgson, ALM
    Johnson, MA
    [J]. VACCINE, 2000, 18 (11-12) : 1040 - 1050